AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Innoplexus’ CTP model forecasts the outcome of clinical studies and may serve as an early indicator for future stock movements.
Gene therapy promises to hold the cure to a number of diseases which, until now, have been considered incurable. By replacing a faulty gene in a patient’s DNA or repairing a defective gene by gene editing, gene therapy can provide a one-time treatment option for diseases such as genetic blindness, muscular dystrophy, blood cancer. Read our recent whitepaper: Advancements in gene therapy – usage of AAV vectors here.